# A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)

> clinical trial · VERIFIED · 2026-07-20

Status: NOT_YET_RECRUITING · Sponsor: Genentech, Inc. · Condition: Systemic Lupus Erythematosus

- Company: Genentech, Inc.
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06984341

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.